Provided by Tiger Fintech (Singapore) Pte. Ltd.

CANSINOBIO

34.600
+0.3000.87%
Volume:1.20M
Turnover:41.30M
Market Cap:8.55B
PE:-20.72
High:35.100
Open:34.300
Low:33.500
Close:34.300
Loading ...

HK Movers | HK's Pharma Shares Soar. Hengrui Pharma Surges 29%; Asymchem up 7%; CSPC Pharma up 4%

Tiger Newspress
·
23 May

HK Movers | HK's Biotech Shares Soar. Asymchem up 15%; Laekna up 13%; Ascletis, CanSinoBIO up 9%

Tiger Newspress
·
21 May

CanSino Biologics Gets Clinical Trial Approval for TB Vaccine from Indonesian Regulator

MT Newswires Live
·
15 May

CanSino Biologics Narrows Loss in Q1

MT Newswires Live
·
30 Apr

CanSino Biologics' 2024 Loss Narrows as Revenue Surges 137%

MT Newswires Live
·
27 Feb

CanSino Biologics Gets Clinical Trial Appproval from NMPA for Influenzae Type B Vaccine

MT Newswires Live
·
24 Feb

BRIEF-CanSino Biologics Says DTcP-Hib-MCV4 Combined Vaccine Obtains Clinical Trial Approval By NMPA China

Reuters
·
24 Feb

BUZZ-CanSino jumps as NMPA grants priority review status to infant vaccine application

Reuters
·
10 Feb

CanSino Biologics Combined Vaccine for Infants Gets Priority Review Status from Chinese Regulator

MT Newswires Live
·
07 Feb

Chinese Regulator Accepts CanSino Biologics' New Drug Application for Tetanus Vaccine

MT Newswires Live
·
06 Feb

BUZZ-China's CanSino climbs on forecasting narrowing loss, higher FY revenue

Reuters
·
20 Jan

CanSino Biologics Expects Narrower Attributable Loss in 2024

MT Newswires Live
·
17 Jan

CanSino Biologics Gets Registration Certificate for Meningitis Vaccine in Indonesia

MT Newswires Live
·
30 Dec 2024

CanSino Biologics Begins Trial for Tetanus, Diptheria, Acellular Pertussis Shots

MT Newswires Live
·
23 Dec 2024

CanSino Biologics Polio Vaccine Trials Gets First Patient Enrollment

MT Newswires Live
·
23 Dec 2024

CanSino Biologics' NDA for Combined Vaccine Accepted in China

MT Newswires Live
·
16 Dec 2024